Quarterly Transactions Made in Crispr Therapeutics Ag (CRSP)
This table provides information about the institutional ownership of Crispr Therapeutics Ag (CRSP). The information is specifically focused on institutions that hold shares of CRISPR Therapeutics AG.
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2022 | 5,087,685 | 3,847,354 | 8,935,039 | 6,428,544 | 800 | 6,429,344 | 2,505,695 | |
| Q4 2022 | 3,760,950 | 1,555,087 | 5,316,037 | 4,822,236 | 112,571 | 4,934,807 | 381,230 | |
| Q1 2023 | 3,410,078 | 1,387,331 | 4,797,409 | 2,747,717 | 60 | 2,747,777 | 2,049,632 | |
| Q2 2023 | 1,513,122 | 1,499,360 | 3,012,482 | 4,478,016 | 590,577 | 5,068,593 | -2,056,111 | |
| Q3 2023 | 2,074,710 | 1,518,375 | 3,593,085 | 1,802,957 | 666,768 | 2,469,725 | 1,123,360 | |
| Q4 2023 | 3,212,882 | 2,979,338 | 6,192,220 | 3,697,672 | 0 | 3,697,672 | 2,494,548 | |
| Q1 2024 | 6,683,352 | 4,494,419 | 11,177,771 | 4,980,722 | 0 | 4,980,722 | 6,197,049 | |
| Q2 2024 | 4,153,567 | 2,071,213 | 6,224,780 | 3,536,853 | 1,114 | 3,537,967 | 2,686,813 | |
| Q3 2024 | 3,954,572 | 601,134 | 4,555,706 | 2,218,634 | 0 | 2,218,634 | 2,337,072 | |
| Q4 2024 | 7,515,609 | 2,891,455 | 10,407,064 | 2,158,935 | 0 | 2,158,935 | 8,248,129 | |
| Q1 2025 | 7,066,779 | 966,077 | 8,032,856 | 7,420,479 | 201 | 7,420,680 | 612,176 | |
| Q2 2025 | 8,450,324 | 3,303,817 | 11,754,141 | 4,676,556 | 32 | 4,676,588 | 7,077,553 | |
| Q3 2025 | 6,727,667 | 668,394 | 7,396,061 | 6,275,469 | 0 | 6,275,469 | 1,120,592 | |